2-84449762-TAAAAAAAAAAAAAAA-TAAAAAAAAAAAA
Variant summary
Our verdict is Benign. Variant got -16 ACMG points: 0P and 16B. BP6_Very_StrongBA1
The NM_003849.4(SUCLG1):c.98-13_98-11del variant causes a splice polypyrimidine tract, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.383 in 772,734 control chromosomes in the GnomAD database, including 28,306 homozygotes. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.74 ( 25329 hom., cov: 0)
Exomes 𝑓: 0.34 ( 2977 hom. )
Consequence
SUCLG1
NM_003849.4 splice_polypyrimidine_tract, intron
NM_003849.4 splice_polypyrimidine_tract, intron
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 0.0610
Genes affected
SUCLG1 (HGNC:11449): (succinate-CoA ligase GDP/ADP-forming subunit alpha) This gene encodes the alpha subunit of the heterodimeric enzyme succinate coenzyme A ligase. This enzyme is targeted to the mitochondria and catalyzes the conversion of succinyl CoA and ADP or GDP to succinate and ATP or GTP. Mutations in this gene are the cause of the metabolic disorder fatal infantile lactic acidosis and mitochondrial DNA depletion. [provided by RefSeq, Feb 2010]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -16 ACMG points.
BP6
Variant 2-84449762-TAAA-T is Benign according to our data. Variant chr2-84449762-TAAA-T is described in ClinVar as [Benign]. Clinvar id is 337162.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-84449762-TAAA-T is described in Lovd as [Likely_benign].
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.844 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SUCLG1 | NM_003849.4 | c.98-13_98-11del | splice_polypyrimidine_tract_variant, intron_variant | ENST00000393868.7 | NP_003840.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SUCLG1 | ENST00000393868.7 | c.98-13_98-11del | splice_polypyrimidine_tract_variant, intron_variant | 1 | NM_003849.4 | ENSP00000377446 | P1 |
Frequencies
GnomAD3 genomes AF: 0.739 AC: 66527AN: 90048Hom.: 25340 Cov.: 0
GnomAD3 genomes
AF:
AC:
66527
AN:
90048
Hom.:
Cov.:
0
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.336 AC: 229157AN: 682680Hom.: 2977 AF XY: 0.330 AC XY: 116881AN XY: 354582
GnomAD4 exome
AF:
AC:
229157
AN:
682680
Hom.:
AF XY:
AC XY:
116881
AN XY:
354582
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.739 AC: 66508AN: 90054Hom.: 25329 Cov.: 0 AF XY: 0.734 AC XY: 30496AN XY: 41564
GnomAD4 genome
AF:
AC:
66508
AN:
90054
Hom.:
Cov.:
0
AF XY:
AC XY:
30496
AN XY:
41564
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Mitochondrial DNA depletion syndrome 9 Benign:3
Benign, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | Apr 29, 2022 | - - |
Benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jun 14, 2016 | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Mar 09, 2022 | - - |
not provided Benign:2
Likely benign, no assertion criteria provided | clinical testing | Mayo Clinic Laboratories, Mayo Clinic | Oct 12, 2017 | - - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | May 29, 2018 | - - |
Mitochondrial DNA depletion syndrome Benign:1
Benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jun 14, 2016 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at